NEW YORK (GenomeWeb) – Immunodiagnostic firm Singulex said today that it closed a $50 million senior secured debt facility with Perceptive Advisors. The firm plans to use the financing to continue to develop its single-molecule counting technology that detects disease-associated biomarkers.

Cantor Fitzgerald acted as exclusive financial advisor and sole placement agent to Singulex.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.